The Nigerian Senate has raised alarm over the continued sale and consumption of over 42 Anti-malaria drugs that have been banned in Europe and other countries. On Tuesday, Sen. T. Orji who raised a motion on the matter lamented that the delay or outright refusal by the Ministry of Health to enforce similar ban in the country was exposing Nigerians to grave danger.
The Senate after brief deliberation mandated the Senate Committee on Health to investigate the matter and submit its report for further necessary action. The banned drugs were listed as "Alaxin 60mg tablet (dihydroartémisinine)B/8; Alaxin oral suspension (dihydroartémisinine) FL/80ml; Amodiaquine 200mg compressed B/1000; Amodiaquine 200mg compressed B/1000; Arinate 100mg tablet (artésunate) B/6; Arinate 50mg tablet (artésunate) B/6; Arsumax 50mg tablet (artésunate) B/12; Artemax 60mg tablet (dihydroartémisinine) B/8; Artémédine 40mg capsule (artemether) B/12; Artémédine 50mg tablet (artemether) B/12; and Artenam 50mg tablet (artemether) B/14."
The list also include "Camoquin 200mg tablet (amodiaquine) B/55 blisters; Camoquin 200mg tablet (amodiquine) B/24; Camoquin 600 mg tablet (amodiaquine) B/3; Camoquin oral suspension 50mg/ 5ml (amodiaquine) FL/60ml; Cotecxin oral suspension (dihydroartémisinine) FL/80ml; Cotecxin 60mg tablet (dihydroartémisinine) B/8; Daraprim tablet (pyriméthamine) B/30; and Falcinil 50mg tablet (artésunate) B/12."
Others are "Artenam 60mg tablet (artemether) B/8; Artésiane 300mg child powder oral suspension (artemether) FL/38g; Artésunate 100mg compressed B/120; Artésunate 50mg tablet B/120; Artexin 60mg tablet (dihydroartémisinine) B/8; Camoquin 200mg tablet (amodiaquine) B/9; Camoquin 200mg tablet (amodiaquine) B/25 blisters.”
